BB Biotech AG announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was CHF 144.259 million compared to CHF 1,191.239 million a year ago. Net income was CHF 128.547 million compared to CHF 1,179.660 million a year ago. Basic earnings per share from continuing operations was CHF 2.32 compared to CHF 21.29 a year ago. For the half year, total revenue was CHF 379.817 million compared to CHF 444.759 million a year ago. Net income was CHF 349.495 million compared to CHF 421.706 million a year ago. Basic earnings per share from continuing operations was CHF 6.31 compared to CHF 7.61 a year ago.